{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T11:42:34Z","timestamp":1771069354255,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","neurosurgery.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurosurgery Clinics of North America"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.nec.2016.11.011","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T08:30:57Z","timestamp":1486024257000},"page":"287-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Perioperative Management of Anticoagulation"],"prefix":"10.1016","volume":"28","author":[{"given":"Daipayan","family":"Guha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Loch","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.nec.2016.11.011_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrcardio.2009.187","article-title":"The CVD paradox: mortality vs prevalence","volume":"6","author":"Fuster","year":"2009","journal-title":"Nat Rev Cardiol"},{"issue":"18","key":"10.1016\/j.nec.2016.11.011_bib2","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.nec.2016.11.011_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jcin.2007.11.004","article-title":"Dual antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients taking chronic oral anticoagulation","volume":"1","author":"Rogacka","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.nec.2016.11.011_bib4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1472-8206.2009.00769.x","article-title":"Aspirin in the secondary prevention of cardiovascular disease: an update of the APTC meta-analysis","volume":"24","author":"Li\u00e8vre","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"issue":"9526","key":"10.1016\/j.nec.2016.11.011_bib5","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.nec.2016.11.011_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10143-011-0349-y","article-title":"The surgical management of chronic subdural hematoma","volume":"35","author":"Ducruet","year":"2012","journal-title":"Neurosurg Rev"},{"issue":"1","key":"10.1016\/j.nec.2016.11.011_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02352062","article-title":"Aspirin as a risk factor for hemorrhage in patients with head injuries","volume":"15","author":"Reymond","year":"1992","journal-title":"Neurosurg Rev"},{"issue":"11","key":"10.1016\/j.nec.2016.11.011_bib8","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7326\/0003-4819-120-11-199406010-00001","article-title":"Risk factors for intracranial hemorrhage in outpatients taking warfarin","volume":"120","author":"Hylek","year":"1994","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.nec.2016.11.011_bib9","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1161\/STROKEAHA.112.650614","article-title":"Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial","volume":"43","author":"Hart","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.nec.2016.11.011_bib10","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00701-012-1399-9","article-title":"Independent predictors for recurrence of chronic subdural hematoma","volume":"154","author":"Chon","year":"2012","journal-title":"Acta Neurochir"},{"issue":"8","key":"10.1016\/j.nec.2016.11.011_bib11","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jocn.2009.11.023","article-title":"The influence of preoperative anticoagulation on outcome and quality of life after surgical treatment of chronic subdural hematoma","volume":"17","author":"Forster","year":"2010","journal-title":"J\u00a0Clin Neurosci"},{"issue":"6","key":"10.1016\/j.nec.2016.11.011_bib12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/02688690120097822","article-title":"Warfarin and chronic subdural haematomas","volume":"15","author":"Gonugunta","year":"2001","journal-title":"Br J Neurosurg"},{"issue":"8","key":"10.1016\/j.nec.2016.11.011_bib13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jocn.2004.12.013","article-title":"Chronic subdural haematomas and anticoagulation or anti-thrombotic therapy","volume":"13","author":"Rust","year":"2006","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.nec.2016.11.011_bib14","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00701-005-0616-1","article-title":"Treatment of chronic subdural hematoma by burr-hole craniostomy in adults: influence of some factors on postoperative recurrence","volume":"147","author":"Stanisic","year":"2005","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.nec.2016.11.011_bib15","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1227\/01.NEU.0000335782.60059.17","article-title":"Independent predictors for recurrence of chronic subdural hematoma: a review of 343 consecutive surgical cases","volume":"63","author":"Torihashi","year":"2008","journal-title":"Neurosurgery"},{"key":"10.1016\/j.nec.2016.11.011_bib16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.wneu.2016.05.049","article-title":"Factors affecting outcome in treatment of chronic subdural hematoma in ICU patients: impact of anticoagulation","volume":"92","author":"Szczygielski","year":"2016","journal-title":"World Neurosurg"},{"issue":"2","key":"10.1016\/j.nec.2016.11.011_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jamaneurol.2015.3682","article-title":"Early clinical and radiological course, management, and outcome of intracerebral hemorrhage related to new oral anticoagulants","volume":"73","author":"Purrucker","year":"2016","journal-title":"JAMA Neurol"},{"issue":"11","key":"10.1016\/j.nec.2016.11.011_bib18","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/STROKEAHA.115.009893","article-title":"Validation of the 9-Point and 24-Point hematoma expansion prediction scores and derivation of the PREDICT A\/B scores","volume":"46","author":"Huynh","year":"2015","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.nec.2016.11.011_bib19","first-page":"248","article-title":"Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis","volume":"102","author":"Jennings","year":"2009","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.nec.2016.11.011_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1152\/physrev.00016.2011","article-title":"New fundamentals in hemostasis","volume":"93","author":"Versteeg","year":"2013","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.nec.2016.11.011_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1538-7836.2008.03220.x","article-title":"New insights into the molecular mechanisms of the fibrinolytic system","volume":"7","author":"Rijken","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9990","key":"10.1016\/j.nec.2016.11.011_bib22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(15)60243-4","article-title":"Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments","volume":"386","author":"Mega","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.nec.2016.11.011_bib23","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/01.CIR.102.6.624","article-title":"Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study","volume":"102","author":"Bertrand","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.nec.2016.11.011_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.amjsurg.2013.04.004","article-title":"Antiplatelet and anticoagulation medications and the surgical patient","volume":"207","author":"Yorkgitis","year":"2014","journal-title":"Am J Surg"},{"issue":"10","key":"10.1016\/j.nec.2016.11.011_bib25","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.nec.2016.11.011_bib26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1538-7836.2006.02245.x","article-title":"Normalization of platelet reactivity in clopidogrel-treated subjects","volume":"5","author":"Vilahur","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.nec.2016.11.011_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/bph.12108","article-title":"A\u00a0comparison of the pharmacological profiles of prasugrel and ticagrelor assessed by platelet aggregation, thrombus formation and haemostasis in rats","volume":"169","author":"Sugidachi","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.nec.2016.11.011_bib28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1056\/NEJMc1409373","article-title":"Inefficacy of platelet transfusion to reverse ticagrelor","volume":"372","author":"Godier","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.nec.2016.11.011_bib29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11883-012-0258-8","article-title":"Anticoagulation-related intracranial hemorrhages","volume":"14","author":"Mittal","year":"2012","journal-title":"Curr Atheroscler Rep"},{"issue":"5","key":"10.1016\/j.nec.2016.11.011_bib30","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/2013.2.FOCUS1328","article-title":"The role of anticoagulants, antiplatelet agents, and their reversal strategies in the management of intracerebral hemorrhage","volume":"34","author":"James","year":"2013","journal-title":"Neurosurg Focus"},{"issue":"6","key":"10.1016\/j.nec.2016.11.011_bib31","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/01.STR.0000221786.81354.d6","article-title":"Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates","volume":"37","author":"Huttner","year":"2006","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.nec.2016.11.011_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12028-015-0222-x","article-title":"Guideline for Reversal of antithrombotics in intracranial hemorrhage","volume":"24","author":"Frontera","year":"2016","journal-title":"Neurocrit Care"},{"issue":"20","key":"10.1016\/j.nec.2016.11.011_bib33","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","article-title":"Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage","volume":"358","author":"Mayer","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.nec.2016.11.011_bib34","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jocn.2009.11.020","article-title":"A\u00a0meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia","volume":"17","author":"Yuan","year":"2010","journal-title":"J\u00a0Clin Neurosci"},{"issue":"3","key":"10.1016\/j.nec.2016.11.011_bib35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.thromres.2005.08.005","article-title":"Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial","volume":"118","author":"van Aart","year":"2006","journal-title":"Thromb Res"},{"issue":"14","key":"10.1016\/j.nec.2016.11.011_bib36","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1016\/j.clinthera.2011.01.011","article-title":"Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United Kingdom","volume":"32","author":"Guest","year":"2010","journal-title":"Clin Ther"},{"issue":"14","key":"10.1016\/j.nec.2016.11.011_bib37","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1161\/CIRCULATIONAHA.111.029017","article-title":"Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects","volume":"124","author":"Eerenberg","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.nec.2016.11.011_bib38","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.thromres.2014.12.019","article-title":"More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate","volume":"135","author":"Lindahl","year":"2015","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.nec.2016.11.011_bib39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11318170-000000000-00000","article-title":"Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate","volume":"49","author":"Stangier","year":"2010","journal-title":"Clin Pharmacokinet"},{"issue":"9994","key":"10.1016\/j.nec.2016.11.011_bib40","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0140-6736(15)60732-2","article-title":"Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial","volume":"386","author":"Glund","year":"2015","journal-title":"Lancet"},{"issue":"10 Supplement 2","key":"10.1016\/j.nec.2016.11.011_bib41","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2146\/ajhp150959","article-title":"Reversal agents for use with direct and indirect anticoagulants","volume":"73","author":"Smythe","year":"2016","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.nec.2016.11.011_bib42","first-page":"35","article-title":"Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet\u00a0alfa, and idarucizumab","volume":"12","author":"Hu","year":"2016","journal-title":"Vasc Health Risk Manag"},{"issue":"7","key":"10.1016\/j.nec.2016.11.011_bib43","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1179\/174313209X459129","article-title":"Impact of platelet transfusion on hematoma expansion in patients receiving antiplatelet agents before intracerebral hemorrhage","volume":"32","author":"Ducruet","year":"2010","journal-title":"Neurol Res"},{"issue":"1","key":"10.1016\/j.nec.2016.11.011_bib44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12028-011-9619-3","article-title":"Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage","volume":"16","author":"Naidech","year":"2012","journal-title":"Neurocrit Care"},{"issue":"4","key":"10.1016\/j.nec.2016.11.011_bib45","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1227\/01.NEU.0000351769.39990.16","article-title":"Reduced platelet activity is associated with more intraventricular hemorrhage","volume":"65","author":"Naidech","year":"2009","journal-title":"Neurosurgery"},{"issue":"10038","key":"10.1016\/j.nec.2016.11.011_bib46","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","article-title":"Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial","volume":"387","author":"Baharoglu","year":"2016","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.nec.2016.11.011_bib47","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1161\/STROKEAHA.114.006061","article-title":"Desmopressin improves platelet activity in acute intracerebral hemorrhage","volume":"45","author":"Naidech","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.nec.2016.11.011_bib48","doi-asserted-by":"crossref","first-page":"298767","DOI":"10.1155\/2014\/298767","article-title":"Desmopressin acetate in intracranial haemorrhage","volume":"2014","author":"Kapapa","year":"2014","journal-title":"Neurol Res Int"},{"issue":"10","key":"10.1016\/j.nec.2016.11.011_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17100","article-title":"The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients","volume":"17","author":"Roberts","year":"2013","journal-title":"Health Technol Assess"},{"issue":"2","key":"10.1016\/j.nec.2016.11.011_bib50","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3171\/2013.3.JNS122162","article-title":"Nonsurgical treatment of chronic subdural hematoma with tranexamic acid","volume":"119","author":"Kageyama","year":"2013","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.nec.2016.11.011_bib51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.wneu.2016.03.062","article-title":"Tranexamic acid for treatment of residual subdural hematoma after bedside twist-drill evacuation","volume":"91","author":"Tanweer","year":"2016","journal-title":"World Neurosurg"},{"issue":"1","key":"10.1016\/j.nec.2016.11.011_bib52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13063-016-1358-5","article-title":"Tranexamic Acid in Chronic Subdural Hematomas (TRACS): study protocol for a randomized controlled trial","volume":"17","author":"Iorio-Morin","year":"2016","journal-title":"Trials"},{"issue":"12","key":"10.1016\/j.nec.2016.11.011_bib53","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1172\/JCI63375","article-title":"Tranexamic acid concentrations associated with human seizures inhibit glycine receptors","volume":"122","author":"Lecker","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.nec.2016.11.011_bib54","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ddr.21105","article-title":"Antifibrinolytic therapy in intracranial hemorrhage","volume":"74","author":"Meier","year":"2013","journal-title":"Drug Dev Res"},{"issue":"3","key":"10.1016\/j.nec.2016.11.011_bib55","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3171\/2015.2.JNS141889","article-title":"Timing of the resumption of antithrombotic agents following surgical evacuation of chronic subdural hematomas: a retrospective cohort study","volume":"124","author":"Guha","year":"2016","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.nec.2016.11.011_bib56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/02688697.2013.812184","article-title":"Recommencement of anticoagulation in chronic subdural haematoma: a systematic review and meta-analysis","volume":"28","author":"Chari","year":"2014","journal-title":"Br J Neurosurg"},{"issue":"5","key":"10.1016\/j.nec.2016.11.011_bib57","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0090-3019(95)00249-9","article-title":"Management of intracranial hemorrhage associated with anticoagulant therapy","volume":"44","author":"Kawamata","year":"1995","journal-title":"Surg Neurol"},{"issue":"7","key":"10.1016\/j.nec.2016.11.011_bib58","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1089\/neu.2011.2074","article-title":"Safety of early warfarin resumption following burr hole drainage for warfarin-associated subacute or chronic subdural hemorrhage","volume":"29","author":"Yeon","year":"2012","journal-title":"J\u00a0Neurotrauma"},{"issue":"7","key":"10.1016\/j.nec.2016.11.011_bib59","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/CIRCULATIONAHA.111.060061","article-title":"Use of the CHA2DS2-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation","volume":"126","author":"Lane","year":"2012","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.nec.2016.11.011_bib60","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.nec.2016.11.011_bib61","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.nec.2016.11.011_bib62","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A\u00a0new risk scheme to predict warfarin-associated hemorrhage","volume":"58","author":"Fang","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Neurosurgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368016301085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368016301085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T18:01:15Z","timestamp":1536084075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042368016301085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1042368016301085"],"URL":"https:\/\/doi.org\/10.1016\/j.nec.2016.11.011","relation":{},"ISSN":["1042-3680"],"issn-type":[{"value":"1042-3680","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative Management of Anticoagulation","name":"articletitle","label":"Article Title"},{"value":"Neurosurgery Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nec.2016.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}